Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

Signos announced today that it launched its FDA-cleared over-the-counter glucose monitoring system for weight management.

The FDA says it will use artificial intelligence to expedite the approval of new drugs and devices. Investigators with the legal services watchdog group, Drugwatch.com point out some of the problems ...

Precigen, Inc. (NASDAQ:PGEN) is one of the best multibagger penny stocks to buy according to analysts. On August 15, the ...

Nerveblox, the ultrasound AI for regional anaesthesia receives US FDA 510(k) clearance: Ankara Wednesday, August 20, 2025, 15:00 Hrs [IST] Nerveblox, an AI software solution by Sm ...

The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy will be ...

To date, 96% of authorized AI- and machine-learning-enabled medical devices have 510 (k) clearance, while only three devices have gone through the FDA’s more rigorous premarket approval process.